In the wake of the increase in Current Liabilities in the fourth quarter 2025, Quick Ratio fell to 3.28 below Nano X Imaging Ltd average.

Within Medical Laboratories industry 13 other companies have achieved higher Quick Ratio than Nano X Imaging Ltd in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from to 823.

Explain Quick Ratio?
How much Cash & cash equivalents NNOX�s has?
What are NNOX�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NNOX Quick Ratio	(Dec 31 2025) Q4	0 Q3	0 Q2	0 Q1	(Dec 31 2024) Q4
Y / Y Current Liabilities Change	96.45 %	15.17 %	15.17 %	15.17 %	-37 %
Y / Y Cash & cash equivalent Change	-18.57 %	-27.91 %	-27.64 %	-27.64 %	178.4 %
Quick Ratio MRQ	3.28	3.53	3.53	3.53	7.92
NNOX's Total Ranking	# 823	#	#	#	#
Seq. Current Liabilities Change	7.46 %	0 %	0 %	82.81 %	-37 %
Seq. Cash & cash equivalent Change	0 %	0 %	0 %	-18.57 %	-11.47 %

Quick Ratio fourth quarter 2025 Company Ranking
Within:	No.
Medical Laboratories Industry	# 14
Healthcare Sector	# 354
Overall Market	# 823

Quick Ratio Statistics
High	Average	Low
5.62	3.48	1.68
(Dec 31 2023)		(Dec 31 2021)

Financial Statements
Nano X Imaging Ltd's Current Liabilities	$ 18 Millions	Visit NNOX's Balance sheet
Nano X Imaging Ltd's Cash & cash equivalent	$ 60 Millions	Visit NNOX's Balance sheet
Source of NNOX's Sales		Visit NNOX's Sales by Geography

Cumulative Nano X Imaging Ltd's Quick Ratio

NNOX's Quick Ratio for the trailling 12 Months

NNOX Quick Ratio	(Dec 31 2025) 12 Months	0 12 Months	0 12 Months	0 12 Months	(Dec 31 2024) 12 Months
Y / Y Current Liabilities TTM Growth	29.28 %	2.13 %	-21.75 %	-34.08 %	-43.69 %
Y / Y Cash & cash equivalent TTM Growth	-25.64 %	-7.93 %	-6.39 %	3.03 %	12.76 %
Quick Ratio TTM	3.47	4.21	4.77	5.37	6.02
Total Ranking TTM	# 2846	#	#	#	#
Seq. Current Liabilities TTM Growth	14.87 %	3.86 %	4.01 %	4.18 %	-9.25 %
Seq. Cash & cash equivalent TTM Growth	-5.39 %	-8.39 %	-7.64 %	-7.1 %	17.14 %

Quick ratio ranking by company, industry and sector >> Back to NNOX Financial Strength Comparisons >> Go to Compare NNOX Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q4 2025 to $18.15 millions, cumulative Quick Ratio decreased to 3.47 above the NNOX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 32 other companies have achieved higher Quick Ratio than Nano X Imaging Ltd. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from to 2846.

Explain Quick Ratio?
How much Cash & cash equivalents NNOX�s has?
What are NNOX�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 33
Healthcare Sector	# 774
Within the Market	# 2846

trailing twelve months Quick Ratio Statistics
High	Average	Low
5.31	2.99	1.68
(Dec 31 2023)		(Dec 31 2021)

Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Laboratories Industry	Quick Ratio	Dec 31 2025 MRQ Cash & cash equivalent	Dec 31 2025 MRQ Current Liabilities
Celcuity Inc	8.12	$ 441.497 Millions	$ 54.405 Millions
Absci Corp	7.14	$ 144.292 Millions	$ 20.221 Millions
Veracyte Inc	6.63	$ 362.578 Millions	$ 54.726 Millions
Personalis Inc	6.05	$ 239.953 Millions	$ 39.630 Millions
Omniab Inc	5.86	$ 54.025 Millions	$ 9.214 Millions
Castle Biosciences Inc	4.36	$ 299.505 Millions	$ 68.677 Millions
Guardant Health Inc	3.97	$ 1,201.598 Millions	$ 302.730 Millions
Fulgent Genetics Inc	3.96	$ 336.077 Millions	$ 84.967 Millions
Nano X Imaging Ltd	3.28	$ 59.610 Millions	$ 18.148 Millions
Grail Inc	3.13	$ 249.727 Millions	$ 79.670 Millions
Hologic Inc	2.49	$ 2,364.700 Millions	$ 947.800 Millions
Exagen Inc	2.28	$ 32.220 Millions	$ 14.159 Millions
Caredx Inc	2.24	$ 201.329 Millions	$ 89.849 Millions
Butterfly Network Inc	2.23	$ 150.489 Millions	$ 67.595 Millions
Bioaffinity Technologies Inc	2.22	$ 6.450 Millions	$ 2.906 Millions
Incyte Corporation	2.04	$ 3,097.817 Millions	$ 1,519.925 Millions
Burning Rock Biotech Limited	1.95	$ 68.752 Millions	$ 35.179 Millions
Sera Prognostics Inc	1.62	$ 39.201 Millions	$ 24.188 Millions
Exact Sciences Corporation	1.59	$ 964.711 Millions	$ 607.561 Millions
Radnet Inc	1.38	$ 807.504 Millions	$ 586.763 Millions
Ispecimen inc	1.11	$ 6.893 Millions	$ 6.231 Millions
Biodesix Inc	1.09	$ 18.987 Millions	$ 17.436 Millions
Medpace Holdings Inc	1.02	$ 497.049 Millions	$ 489.358 Millions
Advanced Biomed Inc.	0.95	$ 2.608 Millions	$ 2.747 Millions

Date modified: 2026-09-08T15:11:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.